Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation
. 2023 Oct 31;15(11):2558.
doi: 10.3390/pharmaceutics15112558.

Solubility and Physical Stability Enhancement of Loratadine by Preparation of Co-Amorphous Solid Dispersion with Chlorpheniramine and Polyvinylpyrrolidone

Affiliations

Solubility and Physical Stability Enhancement of Loratadine by Preparation of Co-Amorphous Solid Dispersion with Chlorpheniramine and Polyvinylpyrrolidone

Krit Suknuntha et al. Pharmaceutics. .

Abstract

Loratadine (LRD), a non-sedating and slow-acting antihistamine, is often given in combination with short-onset chlorpheniramine maleate (CPM) to increase efficacy. However, LRD has poor water solubility resulting in low bioavailability. The aim of this study was to improve LRD solubility by preparing co-amorphous LRD-CPM. However, the obtained co-amorphous LRD-CPM recrystallized rapidly, and the solubility of LRD returned to a poor state again. Therefore, co-amorphous LRD-CPM solid dispersions using polyvinylpyrrolidone (PVP) as a carrier were prepared. The obtained solid dispersions were characterized using X-ray powder diffraction (XRPD), differential scanning calorimetry (DSC), and Fourier transform infrared spectroscopy (FT-IR). The solubility, dissolution, and mechanism of drug release from the LRD-CPM/PVP co-amorphous solid dispersions were studied and compared with those of intact LRD, LRD/PVP solid dispersions, and co-amorphous LRD-CPM mixtures. The results from XRPD and DSC confirmed the amorphous form of LRD in the co-amorphous solid dispersions. The FTIR results indicated that there was no intermolecular interaction between LRD, CPM, and PVP. In conclusion, the obtained LRD-CPM/PVP co-amorphous solid dispersions can successfully increase the water solubility and dissolution of LRD and extend the amorphous state of LRD without recrystallization.

Keywords: amorphous; chlorpheniramine; film casting; loratadine; polyvinylpyrrolidone; quench cooling; solid dispersion; solubility enhancement.

PubMed Disclaimer

Conflict of interest statement

The authors declare no conflict of interest.

Figures

Figure 1
Figure 1
Chemical structure of LRD (A), CPM (B), and PVP (C).
Figure 2
Figure 2
DSC thermograms of the amorphous LRD and co-amorphous LRD-CPM solid dispersions in comparison with the intact drugs and PVP.
Figure 3
Figure 3
XRPD patterns of the amorphous LRD and co-amorphous LRD-CPM solid dispersions in comparison with the intact drugs and co-amorphous mixture of LRD-CPM (am) after being freshly prepared (A) and kept for 30 days (B).
Figure 4
Figure 4
XRPD patterns of the co-amorphous mixture of LRD-CPM (am) after storage for 30 days in comparison with the intact polymorphic forms of LRD.
Figure 5
Figure 5
XRPD patterns of the amorphous LRD and co-amorphous LRD-CPM solid dispersions at 90 days (A), 180 days (B), and 360 days (C) of storage.
Figure 6
Figure 6
FT-IR spectra patterns of the co-amorphous LRD-CPM solid dispersions, CPM/PVP and LRD/PVP solid dispersions, and co-amorphous LRD-CPM mixture in comparison with the intact drugs and PVP (A) and wavenumber amplification in 1900–1300 cm−1 range of LRD/PVP solid dispersion (B), CPM/PVP solid dispersion (C), co-amorphous LRD-CPM mixture (D), and co-amorphous LRD-CPM/PVP solid dispersions (E).
Figure 7
Figure 7
Dissolution profiles of LRD/PVP solid dispersions (A) and co-amorphous LRD-CPM/PVP solid dispersions (B) in comparison with intact LRD, co-amorphous LRD-CPM mixture, and LRD-CPM physical mixture in simulated intestinal fluid pH 6.8.

Similar articles

Cited by

References

    1. Sosnik A., Augustine R. Challenges in oral drug delivery of antiretrovirals and the innovative strategies to overcome them. Adv. Drug Deliv. Rev. 2016;103:105–120. doi: 10.1016/j.addr.2015.12.022. - DOI - PubMed
    1. Vasconcelos T., Sarmento B., Costa P. Solid dispersions as strategy to improve oral bioavailability of poor water soluble drugs. Drug Discov. Today. 2007;12:1068–1075. doi: 10.1016/j.drudis.2007.09.005. - DOI - PubMed
    1. Benes M., Pekarek T., Beranek J., Havlicek J., Krejcik L., Simek M., Tkadlecova M., Dolezal P. Methods for the preparation of amorphous solid dispersions—A comparative study. J. Drug Deliv. Sci. Technol. 2017;38:125–134. doi: 10.1016/j.jddst.2017.02.005. - DOI
    1. Suknuntha K., Jones D.S., Tantishaiyakul V. Properties of felodipine-poly(vinylpyrrolidone) solid dispersion films and the impact of solvents. Sci. Asia. 2012;38:188–195. doi: 10.2306/scienceasia1513-1874.2012.38.188. - DOI
    1. Pandey M.M., Jaipal A., Charde S.Y., Goel P., Kumar L. Dissolution enhancement of felodipine by amorphous nanodispersions using an amphiphilic polymer: Insight into the role of drug-polymer interactions on drug dissolution. Pharm. Dev. Technol. 2016;21:463–474. doi: 10.3109/10837450.2015.1022785. - DOI - PubMed

LinkOut - more resources